ETON financials
Eton Pharmaceuticals (ETON) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ETON income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $79.95M | $42.74M | $72.00K | -$4.60M | -0.17 |
| 2024 | $39.01M | $23.41M | -$2.60M | -$3.82M | -0.15 |
| 2023 | $31.64M | $21.06M | -$1.19M | -$936.00K | -0.04 |
| 2022 | $21.25M | $14.32M | -$8.26M | -$9.02M | -0.36 |
| 2021 | $21.83M | $19.21M | -$1.50M | -$1.96M | -0.08 |
| 2020 | $39.00K | -$247.00K | -$27.11M | -$27.97M | -1.33 |
- ETON revenue was $79.95M in fiscal 2025, net income -$4.60M.
Updated 2026-11-03 13:29 UTC